Repeated pulmonary rehabilitation in severe and disabled COPD patients

Respiration; International Review of Thoracic Diseases
Micaela RomagnoliEnrico M Clini

Abstract

The optimal frequency of delivering a pulmonary rehabilitation program (PR) is not yet a well established issue. It is still unclear whether repeated PR at established intervals will result in effective maintenance or further improvement in the patient's health status. To investigate whether more frequently repeated PR in patients with COPD (1) leads to similar short and long-term physiological gains, and (2) decreases the burden due to hospitalization. Thirty-five disabled COPD patients (FEV(1) below 50% predicted, MRC score 3) in a stable state were studied in a randomized controlled trial. After completing an initial inpatient PR program, they were randomly assigned to either group 1 (performing a second and a third PR after 6 and 12 months) or group 2 (performing only a second PR after 12 months). Lung functions, exercise capacity (by means of a timed walk test - 6MWT), peak-effort dyspnea (D) and leg fatigue (F), and health-related quality of life by means of SGRQ were assessed prior to (T1, T3, T5) and after (T2, T4, T6) each PR program: the same measures were taken on an outpatient basis at T3 in group 2. The number of hospital admissions (HA) and days spent in the hospital (DH) were also recorded over the year. The two ...Continue Reading

References

Sep 1, 1992·The American Review of Respiratory Disease·C BruschiC Grassi
Nov 19, 1994·Lancet·R S GoldsteinG H Guyatt
Jul 31, 1998·Archives of Physical Medicine and Rehabilitation·S Nava
Jun 3, 2000·The European Respiratory Journal·K FoglioN Ambrosino
Oct 20, 2001·Thorax·UNKNOWN British Thoracic Society Standards of Care Subcommittee on Pulmonary Rehabilitation
Jan 30, 2003·Thorax·J Garcia-AymerichUNKNOWN Estudi del Factors de Risc d'Agudització de la MPOC investigators
Mar 22, 2003·Journal of General Internal Medicine·Ghassan F SalmanDavid R Calkins
Feb 12, 2004·Respiration; International Review of Thoracic Diseases·Antonio TramacereEnrico Clini
Jun 29, 2004·The European Respiratory Journal·B R CelliUNKNOWN ATS/ERS Task Force
Feb 5, 2005·Respirology : Official Journal of the Asian Pacific Society of Respirology·UNKNOWN Asia Pacific COPD Roundtable Group
Nov 11, 2005·Chronic Respiratory Disease·E M Clini, M Romagnoli
Mar 1, 1993·The European Respiratory Journal·P H QuanjerJ C Yernault

❮ Previous
Next ❯

Citations

Jun 30, 2009·Journal of Cardiopulmonary Rehabilitation and Prevention·Alejandro Muñoz FernándezV Sevila
Aug 2, 2011·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Neil D Eves, Warren J Davidson
Oct 16, 2007·Respiration; International Review of Thoracic Diseases·Stephan BudweiserMichael Pfeifer
Oct 17, 2013·American Journal of Respiratory and Critical Care Medicine·Martijn A SpruitUNKNOWN ATS/ERS Task Force on Pulmonary Rehabilitation
Aug 21, 2014·Respirology : Official Journal of the Asian Pacific Society of Respirology·Hazel HengAnne E Holland
Apr 10, 2015·Journal of Cardiopulmonary Rehabilitation and Prevention·Ali AtabakiRichard ZuWallack
Feb 11, 2015·PharmacoEconomics·Kunal SrivastavaYogesh Suresh Punekar
May 19, 2009·Respiratory Medicine·Enrico M CliniNicolino Ambrosino
Jul 31, 2021·Annals of Physical and Rehabilitation Medicine·Sara Souto-MirandaAlda Marques

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved